Investors

To download our documents

Events

All events
05/12/2024

Geneva European “Midcap Event”©

December 5, 2024, Geneva

Read more
01/10/2024

Paris European “Midcap Event”©

October 1 - 2, 2024, Paris

Read more
06/06/2024

Spring European “Midcap Event”©

June 6, 2024, Paris

Read more

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price

ISIN

FR0012127173

Ticker

OSE

Type of listing

Continuous

Number of outstanding shares

21,767,777 shares as of April 30, 2024

Eligibility

Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

27 March 2024

Annual financial results 2023

19 June 2024

General shareholders' meeting

26 September 2024

Half-year results 2024

Analysts

Read more
Invest Securities
Jamila El Bougrini
Kepler Cheuvreux
Pierre-Alexandre Desir
Edison
Soo Romanoff

Analyst reports

Read more
25/06/2024 Invest Securities: INITIATION IMMINENTE DE LA PH III "ARTEMIA" AVEC TEDOPI
31/05/2024 Invest Securities: BIEN DÉCIDÉE À FAIRE DE 2024 SON ANNÉE TREMPLIN !
28/05/2024 Invest Securities: ABBVIE, BI : OSE REVIENT EN FORCE SUR LE FRONT BD !

Regulated information

Read more

General shareholders' meetings

Read more
19/06/2024

General Shareholders' Meeting 2024

All the documents below are in French except the Voting form and the Presentation of nominees for the position of director

Voting form

Financial information and publications

Read more
2023 First-half 2023 financial report (in French)
2023 Auditors's report on first-half 2023 financial report (in French)
2023 2022 Universal registration document

To receive OSE Immunotherapeutics’ latest news